---
document_datetime: 2023-09-21 21:09:12
document_pages: 9
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/memantine-ratiopharm-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: memantine-ratiopharm-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.8378506
conversion_datetime: 2025-12-22 17:09:05.62385
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Memantine ratiopharm

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0023               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                               | 03/06/2022                          |                                             | PL                               |           |
| IB/0022              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference | 12/11/2021                          |                                             | SmPC, Annex II, Labelling        |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | - Implementation of change(s) for which NO additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     | and PL   | product new the   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|-------------------|
| IB/0021   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                         | 05/08/2021 | n/a |          |                   |
| IA/0020   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 03/05/2021 | n/a |          |                   |
| IA/0019   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                            | 21/10/2020 | n/a |          |                   |
| IB/0018/G | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of | 14/08/2020 | n/a |          |                   |

<div style=\"page-break-after: always\"></div>

|         | an obsolete parameter) B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.c.z - Container closure system of the AS - Other variation B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor   |            |     |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0017 | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 12/07/2019 | n/a |
| IA/0016 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 26/10/2018 | n/a |

<div style=\"page-break-after: always\"></div>

| N/0015      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                   | 24/07/2018   |            | PL                     |                               |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------------------|
| R/0011      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                            | 22/02/2018   | 13/04/2018 | SmPC, Labelling and PL |                               |
| II/0012     | Croatia Ltd. TAPI Croatia Production SM, Prudni č ka cesta 54 10291, Prigorje, Brdove č ko, Croatia as additional manufacturer of the active substance supported by an ASMF. B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF                    | 15/03/2018   | n/a        |                        | To introduce PLIVA            |
| IA/0014     | A.7 - Administrative change - Deletion of                                                                                                                                                                                                                                                                                                                          | 11/01/2018   | n/a        |                        | manufacturing sites           |
| IAIN/0013/G | This was an application for a group of variations. B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a parameter | 20/11/2017   | 13/04/2018 | SmPC and PL            | non-significant specification |

<div style=\"page-break-after: always\"></div>

| II/0008   | B.II.d.1 e) To change the shelf-life specification for Memantine HCl 5 mg, 10 mg, 15 mg and 20 mg film- coated tablets by widening the water content limit from NMT 5.0% to NMT 6.0% B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change specifications limits range   | 20/07/2017   | n/a        |                                  | outside the approved   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|------------------------|
| IA/0010   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                         | 30/05/2017   | n/a        |                                  |                        |
| IB/0009   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                            | 23/05/2017   | n/a        |                                  |                        |
|           | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                    | 05/04/2017   | n/a        |                                  | IB/0007/G              |
| IB/0006   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                        | 28/06/2016   | 09/08/2016 | SmPC, Annex II, Labelling and PL |                        |
| IB/0005/G | This was an application for a group of variations. B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same                                                                                                                 | 24/02/2016   | n/a        |                                  |                        |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| pharmaceutical group manufacturer B.I.a.1.a - Change in the starting material/reagent/intermediate proposed manufacturer pharmaceutical group manufacturer B.I.a.2.a - Changes in the AS - Minor change of the AS B.I.a.2.e - Changes in the AS - Minor change ASMF B.I.a.2.e - Changes in the AS - Minor change ASMF B.I.a.2.z - Changes in the AS - Other variation B.I.a.3.a - Change in batch ranges) of AS or intermediate increase compared to size B.I.a.3.a - Change in batch ranges) of AS or intermediate increase compared to size B.I.b.1.b - Change in the and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.b - Change in the   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| material/intermediate/reagent specification limits B.I.b.2.e - Change in starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate B.I.z - Quality change variation B.I.z - Quality change variation B.I.a.1.i - Change in the starting material/reagent/intermediate Introduction of a new B.I.a.1.i - Change in the starting material/reagent/intermediate Introduction of a new B.I.a.2.a - Changes in the AS - Minor change of the AS B.I.a.4.c - Change to applied during the manufacture of a non-significant in-process B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.I.b.2.e - Change in starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | material/reagent/intermediate - Other to a test procedure (including replacement addition) for the AS or a starting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |      | starting changes or material/intermediate   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|---------------------------------------------|
| IB/0004   | B.II.f.1.a.1 - Stability of FP - Reduction of the shelf life of the finished product - As packaged for sale                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 14/08/2015 | 09/08/2016 | SmPC |                                             |
| IA/0003   | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 07/08/2015 | n/a        |      |                                             |
| II/0002/G | This was an application for a group of variations. B.II.b.5.d - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of an in-process test which may have a significant effect on the overall quality of the finished product B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.d.2.f - Change in test procedure for the finished product - To reflect compliance with the Ph. Eur. and remove reference to the outdated internal test method and test method number B.II.d.2.f - Change in test procedure for the finished product - To reflect compliance with the Ph. Eur. and remove reference to the outdated internal test method and test method number | 26/03/2015 | n/a        |      |                                             |

<div style=\"page-break-after: always\"></div>

|         | B.II.d.2.f - Change in test procedure for the finished product - To reflect compliance with the Ph. Eur. and remove reference to the outdated internal test method and test method number   |            |            |                        |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0001 | B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product                                                                    | 16/12/2013 | 15/01/2015 | SmPC, Labelling and PL |